View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Dermapharm Holding SE: 1 director

A director at Dermapharm Holding SE bought 100,000 shares at 34.940EUR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two year...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Kinepolis: June 2025 Box office revenue/ attendance in US/Canada and France down. Utilities – Offshore Wind: Big Not So Beautiful Bill

Dirk Verbiesen ... (+5)
  • Dirk Verbiesen
  • Marc Zwartsenburg
  • CEFA
  • Quirijn Mulder
  • Tijs Hollestelle

Utilities and offshore wind supply chain sector/Mind the gaps

In this report we present our view on the long-term growth prospects for offshore wind in Europe, implications of the energy transition and the role of TSOs, such as Elia Group. We also focus on supply chain beneficiaries in our Benelux coverage. An increasing number of long-term framework contracts should provide improved risk-rewards to the supply chain, in our view. Furthermore, we take a deep dive into growth drivers and long-term financing for Elia Group, beyond the company's current financ...

Tijs Hollestelle
  • Tijs Hollestelle

Sif Group/Quality is never an accident, but it takes time/BUY

The first XXL monopiles manufactured in Sif's new factory concerned foundations for Empire Wind. As such it was a relief that the US Department of the Interior's Bureau of Ocean Energy Management notified Equinor that the stop-work order for Empire Wind 1 offshore wind project, issued on 16 April, had been lifted. Sif is finalising production of this much debated US project now and is starting up production for the Dutch Ecowende project. We visited the factory on 14 May and compared to our prio...

Oliver Metzger ... (+2)
  • Oliver Metzger
  • Stephan Wulf
ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Alfen: Dead cat bounce? Ayvens: Overhang cure. Belgian telcos: Hey! discontinues €5 offer, OBEL price increases from June 2025. B&S Group: Pulls FY EBITDA guidance in light of tariffs. D'Ieteren: CMD, 1Q25 Preview. Kendrion: Wrestling through difficult macro conditions. NN Group, ASR: Vote on Dutch pension reforms postponed. TKH Group: Not that bad, good progress at Eemshaven. UCB: US Most Favoured Nation initiative back on the agenda. Vastned: Good results, integration ongoing...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Aedifica, Cofinimmo: Aedifica CMD feedback bpost: 1Q25 results beat strongly, outlook surprises Brunel: 1Q25 results disappoint on perm, weak revenue Cofinimmo, Aedifica: Negative reaction on Aedifica offer Eurocommercial Properties: Good with no surprise Montea: Good results, guidance reconfirmed Proximus: Small 1Q beat, guidance reiterated, soft commercial performance Sif Group: The jury is still out Talabat: Preview 1Q25 Universal Music Group: Peer Warner Music slowdown in streaming and prof...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Ahold Delhaize: Strong 1Q25 in the US, additional details on FY25 guidance. Arcadis: Mixed start to FY25, US not to blame. PostNL: Highlights of 1Q25 analyst meeting. Sif Group: Preview - EBITDA capacity of new factory is key. Vonovia: Good results, positive message about valuations, new CEO. Wolters Kluwer: 1Q25 trading update – good start to the year

Thijs Berkelder
  • Thijs Berkelder
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch